Aminoguanidine normalizes ET-1-induced aortic contraction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats by suppressing Jab1-mediated increase in ET A-receptor expression

Peptides

Volumn 33, Issue 1, 2012, Pages 109-119

  Nemoto, Shingo ^a   Taguchi, Kumiko ^a   Matsumoto, Takayuki ^a   Kamata, Katsuo ^a   Kobayashi, Tsuneo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Diabetes; Endothelin 1; ET A R; Jab1; O GlcNAc; Otsuka Long Evans Tokushima Fatty rat

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN CONVERTING ENZYME; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; VASOCONSTRICTION;

ACETYLGLUCOSAMINE; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DINOPROSTONE; ENDOTHELIN-1; ENDOTHELINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; INSULIN; MALE; PEPTIDE FRAGMENTS; PHENYLEPHRINE; PHOSPHORYLATION; PROTEINS; RATS; RATS, INBRED OLETF; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; VASOCONSTRICTION;

RATTUS;

EID: 84855775820     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.11.018     Document Type: Article

References (67)

1. W.G. An, M. Kanekal, M.C. Simon, E. Maltepe, M.V. Blagosklonny, and L.M. Neckers Stabilization of wild-type p53 by hypoxia-inducible factor 1α Nature 392 1998 405 408
2. H. Arai, S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi Cloning and expression of a cDNA encoding an endothelin receptor Nature 348 1990 730 732 (Pubitemid 120015147)
3. M.K. Bae, M.Y. Ahn, J.W. Jeong, M.H. Bae, Y.M. Lee, and S.K. Bae Jab1 interacts directly with HIF-1alpha and regulates its stability J Biol Chem 277 2002 9 12 (Pubitemid 34952021)
4. M. Brownlee, H. Vlassara, A. Kooney, P. Ulrich, and A. Cerami Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 232 1986 1629 1632 (Pubitemid 16095602)
5. K.C. Chang, C.D. Tseng, M.S. Wu, J.T. Liang, M.S. Tsai, and Y.L. Cho Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes Eur J Clin Invest 36 2006 528 535
6. L. Chen, Y. Liu, B. Cui, Q. Mi, Y. Huang, and L. Fan 17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets Clin Exp Pharmacol Physiol 34 2007 972 978 (Pubitemid 47274552)
7. X. Cheng, and G.W. Hart Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity J Biol Chem 276 2001 10570 10575
8. R.A. Cohen The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease Prog Cardiovasc Dis 38 1995 105 128
9. F.I. Comer, and G.W. Hart O-glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate J Biol Chem 275 2000 29179 29182 (Pubitemid 32043784)
10. A.S. De Vriese, T.J. Verbeuren, J. Van De Voorde, N.H. Lameire, and P.M. Vanhoutte Endothelial dysfunction in diabetes Br J Pharmacol 130 2000 963 974 (Pubitemid 30453529)
11. E.P. Feener, and G.L. King Vascular dysfunction in diabetes mellitus Lancet 350 1997 9 13 (Pubitemid 127673450)
12. A. Giaid, M. Yanagisawa, D. Langleben, R.P. Michel, R. Levy, and H. Shennib Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 1732 1739 (Pubitemid 23170122)
13. K. Goto, H. Hama, and Y. Kasuya Molecular pharmacology and pathophysiological significance of endothelin Jpn J Pharmacol 72 1996 261 290 (Pubitemid 27039161)
14. Y. Hattori, H. Kawasaki, and M. Kanno Increased contractile response to endothelin-1 and U46619 via a protein kinase C-mediated nifedipine-sensitive pathway in diabetic rat aorta Res Commun Mol Pathol Pharmacol 104 1999 73 80 (Pubitemid 29519611)
15. K. Ikeda, T. Higashi, H. Sano, Y. Jinnouchi, M. Yoshida, and T. Araki N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction Biochemistry 35 1996 8075 8083
16. 2 sensing Science 292 2001 464 468 (Pubitemid 32335941)
17. S. Jesmin, Y. Hattori, S. Maeda, S. Zaedi, I. Sakuma, and T. Miyauchi Subdepressor dose of benidipine ameliorates diabetic cardiac remodeling accompanied by normalization of upregulated endothelin system in rats Am J Physiol Heart Circ Physiol 290 2006 H2146 H2154
18. P.J. Kallio, W.J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway J Biol Chem 274 1999 6519 6525 (Pubitemid 29111068)
19. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain Diabetes 41 1992 1422 1428
20. T. Kobayashi, T. Miyauchi, S. Iwasa, S. Sakai, J. Fan, and M. Nagata Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis Pathol Int 50 2000 929 936 (Pubitemid 32128468)
21. T. Kobayashi, T. Nogami, K. Taguchi, T. Matsumoto, and K. Kamata Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK Br J Pharmacol 155 2008 974 983
22. T. Kobayashi, K. Oishi, Y. Hayashi, T. Matsumoto, and K. Kamata Changes in aortic endothelial gene expressions and relaxation responses following chronic short-term insulin treatment in diabetic rats Atherosclerosis 185 2006 47 57 (Pubitemid 43117550)
23. T. Kobayashi, K. Taguchi, S. Nemoto, T. Nogami, T. Matsumoto, and K. Kamata Activation of the PDK1/Akt/eNOS pathway involved in aortic endothelial function differs between hyperinsulinemic and insulin-deficient diabetic rats Am J Physiol Heart Circ Physiol 297 2009 H1767 H1775
24. T. Kobayashi, K. Taguchi, T. Yasuhiro, T. Matsumoto, and K. Kamata Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model Hypertension 44 2004 956 962 (Pubitemid 39577428)
25. V.V. Lima, F.R. Giachini, F.S. Carneiro, Z.N. Carneiro, M.A. Saleh, and D.M. Pollock O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1 Hypertension 55 2010 180 188
26. Y.C. Lin-Lee, L.V. Pham, A.T. Tamayo, L. Fu, H.J. Zhou, and L.C. Yoshimura Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes J Biol Chem 281 2006 18878 18887 (Pubitemid 44035547)
27. T.F. Luscher, M.A. Creager, J.A. Beckman, and F. Cosentino Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II Circulation 108 2003 1655 1661 (Pubitemid 37187795)
28. J.J. Maguire, and A.P. Davenport Endothelin receptor expression and pharmacology in human saphenous vein graft Br J Pharmacol 126 1999 443 450 (Pubitemid 29057595)
29. T. Masaki, J.R. Vane, and P.M. Vanhoutte International Union of Pharmacology nomenclature of endothelin receptors Pharmacol Rev 46 1994 137 142 (Pubitemid 24185148)
30. T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat Am J Physiol Heart Circ Physiol 296 2009 H1388 H1397
31. T. Matsumoto, M. Kakami, T. Kobayashi, and K. Kamata Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice Peptides 29 2008 1338 1346
32. T. Matsumoto, E. Noguchi, K. Ishida, T. Kobayashi, N. Yamada, and K. Kamata Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes Am J Physiol Heart Circ Physiol 295 2008 H1165 H1176
33. T. Matsumoto, E. Noguchi, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpolarizing factor response in mesenteric arteries from Type 2 diabetic rats Eur J Pharmacol 599 2008 102 109
34. T. Matsumoto, Y. Ozawa, K. Taguchi, T. Kobayashi, and K. Kamata Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction Peptides 31 2010 346 353
35. T. Matsumoto, S. Yoshiyama, T. Kobayashi, and K. Kamata Mechanisms underlying enhanced contractile response to endothelin-1 in diabetic rat basilar artery Peptides 25 2004 1985 1994 (Pubitemid 39389194)
36. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, and M.E. Cockman The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275 (Pubitemid 29246458)
37. E.J. Menzel, J. Neumuller, G. Sengoelge, and R. Reihsner Effects of aminoguanidine on adhesion molecule expression of human endothelial cells Pharmacology 55 1997 126 135 (Pubitemid 27417420)
38. T. Miyauchi, and T. Masaki Pathophysiology of endothelin in the cardiovascular system Annu Rev Physiol 61 1999 391 415 (Pubitemid 29143176)
39. A. Namiki, Y. Hirata, M. Ishikawa, M. Moroi, J. Aikawa, and K. Machii Endothelin-1- and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxide Life Sci 50 1992 677 682
40. S. Nemoto, T. Kobayashi, K. Taguchi, T. Matsumoto, and K. Kamata Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats Am J Physiol Heart Circ Physiol September 2011 10.1152/ajpheart.00178.2011
41. A. Nishimoto, L. Lu, M. Hayashi, T. Nishiya, T. Horinouchi, and S. Miwa Jab1 regulates levels of endothelin type A and B receptors by promoting ubiquitination and degradation Biochem Biophys Res Commun 391 2010 1616 1622
42. T.J. Orchard, J.C. Olson, J.R. Erbey, K. Williams, K.Y. Forrest, and L. Smithline Kinder Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetes Care 26 2003 1374 1379 (Pubitemid 36929165)
43. M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, and L.E. Huang Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein Nat Cell Biol 2 2000 423 427
44. D.M. Pollock, T.L. Keith, and R.F. Highsmith Endothelin receptors and calcium signaling FASEB J 9 1995 1196 1204
45. L. Poston, and P.D. Taylor Endothelium-mediated vascular function in insulin-dependent diabetes mellitus Clin Sci 88 1995 245 255
46. C. Rask-Madsen, and G.L. King Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes Nat Clin Pract Endocrinol Metab 3 2007 46 56 (Pubitemid 46006612)
47. R. Ravi, B. Mookerjee, Z.M. Bhujwalla, C.H. Sutter, D. Artemov, and Q. Zeng Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha Genes Dev 14 2000 34 44 (Pubitemid 30051577)
48. S. Reddy, J. Bichler, K.J. Wells-Knecht, S.R. Thorpe, and J.W. Baynes N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins Biochemistry 34 1996 10872 10878
49. G.M. Rubanyi, and M.A. Polokoff Endothelins: molecular biology, biochemistry, pharmacology, physiology, pathophysiology Pharmacol Rev 46 1994 325 415
50. S. Sakai, T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita Inhibition of myocardial endothelin pathway improves long-term survival in heart failure Nature 384 1996 353 355 (Pubitemid 26408515)
51. T. Sakurai, M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, and K. Goto Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature 348 1990 732 735 (Pubitemid 120015148)
52. A.M. Schmidt, O. Hori, J.X. Chen, J.F. Li, J. Crandall, and J. Zhang Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 96 1995 1395 1403
53. T. Soulis, S. Sastra, V. Thallas, S.B. Mortensen, M. Wilken, and J.T. Clausen A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes Diabetologia 42 1999 472 479 (Pubitemid 29148407)
54. J.R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol 286 2004 H1597 H1602
55. J.R. Sowers, M. Epstein, and E.D. Frohlich Diabetes, hypertension, and cardiovascular disease: an update Hypertension 37 2001 1053 1059 (Pubitemid 32304003)
56. F. Sugawara, H. Ninomiya, Y. Okamoto, S. Miwa, O. Mazda, and Y. Katsura Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway Mol Pharmacol 49 1996 447 457
57. J. Su, P.A. Lucchesi, R.A. Gonzalez-Villalobos, D.I. Palen, B.M. Rezk, and Y. Suzuki Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice Arterioscler Thromb Vasc Biol 28 2008 1432 1438
58. M. Takanashi, T. Miyauchi, Y. Kakinuma, K. Goto, and I. Yamaguchi Establishment of hypoxia inducible factor-1alpha overexpressing cells that produce endothelin-1 J Cardiovasc Pharmacol 44 2004 S268 S273
59. M. Ushio-Fukai, J. Nishimura, H. Aoki, S. Kobayashi, and H. Kanaide Endothelin-1 inhibits and enhances contraction of porcine coronary arterial strips with an intact endothelium Biochem Biophys Res Commun 184 1992 518 524
60. M. Ushio-Fukai, J. Nishimura, S. Kobayashi, and H. Kanaide Endothelin-1 and endothelin-3 regulate differently vasoconstrictor responses of smooth muscle of the porcine coronary artery Br J Pharmacol 114 1995 171 179
61. H. Vlassara, H. Fuh, T. Donnelly, and M. Cybulsky Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits Mol Med 1 1995 447 456
62. L. Wells, K. Vosseller, and G.W. Hart Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc Science 291 2001 2376 2378 (Pubitemid 32231793)
63. S.A. Whelan, W.B. Dias, L. Thiruneelakantapillai, M.D. Lane, and G.W. Hart Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes J Biol Chem 285 2010 5204 5211
64. K. Yagi, S. Kim, H. Wanibuchi, T. Yamashita, Y. Yamamura, and H. Iwao Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats Hypertension 29 1997 728 735 (Pubitemid 27097977)
65. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415 (Pubitemid 18090241)
66. X. Yang, P.P. Ongusaha, P.D. Miles, J.C. Havstad, F. Zhang, and W.V. So Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance Nature 451 2008 964 969 (Pubitemid 351301737)
67. F. Zhang, K. Su, X. Yang, D.B. Bowe, A.J. Paterson, and J.E. Kudlow O-GlcNAc modification is an endogenous inhibitor of the proteosome Cell 115 2003 715 725 (Pubitemid 38030300)